Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-077539·Caris Life Sciences, Inc.
Schedule 13G ownership disclosure
Caris Life Sciences Inc
Common Stock · CUSIP: 142152107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- David D. Halbert
Shares: 124,906,296.00 · Class: 44.1%
- Caris Halbert, L.P.
Shares: 101,261,532.00 · Class: 36.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-077539
- Form type
- SCHEDULE 13G
- Filer
- Caris Life Sciences, Inc.
- CIK
- CIK 2019410
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership